Computational design of disulfide cyclic peptide as potential inhibitor of complex NS 2 BNS 3 dengue virus protease

Development of genomic and proteomic studies coupled with computational sciences could facilitate the discovery of various target proteins and potential inhibitor to be developed as drugs. Several researches by molecular docking method have been conducted to design disulfide cyclic peptide ligand as potential inhibitors for NS2B-NS3 protease (NS2B-NS3 pro) of dengue virus serotype DENV-2 in order to inhibit replication of dengue virus. This research studied and evaluated the interaction of ligands and the enzyme in the hydrate state using molecular dynamics simulations at two different temperatures. Simulations were performed using two disulfide cyclic peptide inhibitors KRK and RKR, along with one linear peptide Bz-Nle-K-R-R-H as standard ligand. The result shows that dynamic movement of three proposed ligand in hydrated state affects ligand interactions. RKR ligand has the best affinity with the enzyme than KRK and standard ligand. This is shown by the ligand interaction with enzyme active site which remains stable during the simulation. At the end of simulation 300 K, RKR formed a hydrogen bond with Asp75 and at the end of simulation 312 K, RKR also maintained hydrogen bond with Asp75

[1]  U. Tambunan,et al.  Designing cyclic peptide inhibitor of dengue virus NS3-NS2B protease by using molecular docking approach , 2010, Bioinformation.

[2]  Sangdun Choi,et al.  Molecular modeling of the reductase domain to elucidate the reaction mechanism of reduction of peptidyl thioester into its corresponding alcohol in non-ribosomal peptide synthetases , 2010, BMC Structural Biology.

[3]  Miklos Feher,et al.  Effect of Input Differences on the Results of Docking Calculations , 2009, J. Chem. Inf. Model..

[4]  B. Geiss,et al.  Focus on flaviviruses: current and future drug targets. , 2009, Future medicinal chemistry.

[5]  Suzanne M. Tomlinson,et al.  New approaches to structure-based discovery of dengue protease inhibitors. , 2009, Infectious disorders drug targets.

[6]  A. Sampath,et al.  Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. , 2008, Antiviral research.

[7]  Tin Wee Tan,et al.  Conservation and Variability of Dengue Virus Proteins: Implications for Vaccine Design , 2008, PLoS neglected tropical diseases.

[8]  Subhash G. Vasudevan,et al.  Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution , 2007, Journal of Virology.

[9]  J. Gready,et al.  Combining docking and molecular dynamic simulations in drug design , 2006, Medicinal research reviews.

[10]  Jennifer L. Harris,et al.  Functional Profiling of Recombinant NS3 Proteases from All Four Serotypes of Dengue Virus Using Tetrapeptide and Octapeptide Substrate Libraries*[boxs] , 2005, Journal of Biological Chemistry.

[11]  D. Fairlie,et al.  Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. , 1999, The Journal of general virology.

[12]  S. Vasudevan,et al.  Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. , 2006, Bioorganic & medicinal chemistry letters.